. | Type 1 diabetes . | Type 2 diabetes . | P value . |
---|---|---|---|
n | 1,433 | 68 | |
Age at last assessment (years) | 15.7 (13.9–17.0) | 15.3 (13.6–16.4) | 0.23 |
Age at diagnosis (years) | 8.1 (4.8–10.8) | 13.2 (11.6–15.0) | <0.0001 |
Sex (male/female) | 674/759 | 34/34 | 0.63 |
Duration (years) | 6.8 (4.7–9.6) | 1.3 (0.6–3.1) | <0.0001 |
A1C (%) | 8.5 (7.8–9.5) | 7.3 (6.0–8.3) | <0.0001 |
A1C <7.5% | 230/1,393 (17) | 42/66 (64) | <0.0001 |
Insulin/weight | 1.15 (0.96–1.39) | 0.89 (0.51–1.31) (n = 9) | 0.063 |
BMI SD score | 0.80 (0.25–1.27) | 1.86 (1.28–2.40) | <0.0001 |
Social disadvantage risk score | 0.23 (−0.17–0.80) | 0.14 (−0.47–0.56 | 0.058 |
From urban area | 957/1,419 (67) | 46/63 (73) | 0.56 |
Microalbuminuria | 81/1,325 (6) | 10/36 (28) | <0.0001 |
Hypertension | 223/1,393 (16) | 21/58 (36) | <0.0001 |
Retinopathy | 254/1,264 (20) | 1/25 (4) | 0.043 |
Peripheral nerve abnormality | 375/1,376 (27) | 5/24 (21) | 0.48 |
Pupillary abnormality | 568/928 (61) | 13/23 (57) | 0.65 |
Overweight | 452/1,411 (32) | 16/64 (25) | 0.24 |
Obese | 100/1,411 (7) | 36/64 (56) | <0.0001 |
. | Type 1 diabetes . | Type 2 diabetes . | P value . |
---|---|---|---|
n | 1,433 | 68 | |
Age at last assessment (years) | 15.7 (13.9–17.0) | 15.3 (13.6–16.4) | 0.23 |
Age at diagnosis (years) | 8.1 (4.8–10.8) | 13.2 (11.6–15.0) | <0.0001 |
Sex (male/female) | 674/759 | 34/34 | 0.63 |
Duration (years) | 6.8 (4.7–9.6) | 1.3 (0.6–3.1) | <0.0001 |
A1C (%) | 8.5 (7.8–9.5) | 7.3 (6.0–8.3) | <0.0001 |
A1C <7.5% | 230/1,393 (17) | 42/66 (64) | <0.0001 |
Insulin/weight | 1.15 (0.96–1.39) | 0.89 (0.51–1.31) (n = 9) | 0.063 |
BMI SD score | 0.80 (0.25–1.27) | 1.86 (1.28–2.40) | <0.0001 |
Social disadvantage risk score | 0.23 (−0.17–0.80) | 0.14 (−0.47–0.56 | 0.058 |
From urban area | 957/1,419 (67) | 46/63 (73) | 0.56 |
Microalbuminuria | 81/1,325 (6) | 10/36 (28) | <0.0001 |
Hypertension | 223/1,393 (16) | 21/58 (36) | <0.0001 |
Retinopathy | 254/1,264 (20) | 1/25 (4) | 0.043 |
Peripheral nerve abnormality | 375/1,376 (27) | 5/24 (21) | 0.48 |
Pupillary abnormality | 568/928 (61) | 13/23 (57) | 0.65 |
Overweight | 452/1,411 (32) | 16/64 (25) | 0.24 |
Obese | 100/1,411 (7) | 36/64 (56) | <0.0001 |
Data are median (interquartile range) or n (%) and are from last complications assessment